% Expired Patents = 12.5

Forward Citations = 209

Loading Chart...

3 inventors (with patents filed for the assignee):

Gary M Nath (8 out of 15 patents)

Peter Rothbart (8 out of 15 patents)

Alan Drizen (8 out of 15 patents)

8 patents: Sort by Forward Citations

1. 6723345 - Topical drug preparations (2004-04-20),

2. 6514536 - Drug preparations for treating sexual dysfunction (2003-02-04),

3. 6387407 - Topical drug preparations (2002-05-14),

4. 6346271 - Topical drug preparations (2002-02-12),

5. 6335035 - Sustained release delivery system (2002-01-01),

6. 6335034 - Topical drug preparations (2002-01-01),

7. 6251436 - Drug preparations for treating sexual dysfunction (2001-06-26),

8. 6036977 - Drug preparations for treating sexual dysfunction (2000-03-14),

Company Overview

L.a.m. Pharmaceutical Corporation is a leading pharmaceutical company dedicated to developing and commercializing innovative healthcare solutions. With a focus on improving patient outcomes, we strive to bring high-quality medications to market efficiently and effectively. Our team of experienced professionals is committed to making a positive impact on the healthcare industry through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

8 Patents

#1 in Lewiston, NY

#2,104 in New York

#1,878 in US

Lewiston, NY, United States of America

L.a.m. Pharmaceutical Corporation

Forward Citations = 209

3 inventors:

Gary M Nath (8 out of 15 patents)

Peter Rothbart (8 out of 15 patents)

Alan Drizen (8 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: L.a.m. Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/l-a-m-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]